Biosimilar strategy for drugs treating neutropenia using MedDrive™ - Prime Therapeutics LLC
Filgrastim -Teva®
New Granix Syringes Approved for Self-Administration - MPR
FILGRASTIM Teva 30 mio U/0.5ml ser prê 0.5 ml - Pharmafoto
Tbo-filgrastim Approved for Chemotherapy-Induced Neutropenia - MPR
Teva Pharmaceuticals - Wikipedia
Resources & Support from Teva CORE | GRANIX
Filgrastim (Neupogen) - Uses, Dose, Side effects, Brands
Teva receives FDA approval for filgrastim in the US
GRANIX - Hematology Advisor
These highlights do not include all the information needed to use GRANIX safely and effectively. See full prescribing information for GRANIX.GRANIX® (tbo-filgrastim) injection, for subcutaneous use Initial U.S. Approval: 2012
Japan approves second biosimilar G-CSF
Filgrastim -Teva®
Granix® Hematopoietic Agent TBO-Filgrastim, Preservative Free 480 mcg / 0.8 mL Subcutaneous Injection Prefilled Syringe 5 Syringes - Suprememed
Filgrastim -Teva®
Delays in FDA approval of biosimilar G-CSF (filgrastim)